Healthcare & Life Sciences
Brenig
Netherlands
series-a
series-a
Stage
1
Investors
About
Brenig is developing disease-modifying therapies for Parkinson’s disease and other complex neurodegenerative disorders.
Explore Brenig's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.